PRECISION BIOSCIENCES INC

For the period ended Jun 30, 2024. Filed Aug 1, 2024.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2024 · Filed Aug 1, 2024

DTIL$10.60+7.4%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Statements of Operations

(In thousands, except share and per share amounts)

	For the Three Months Ended June 30,		For the Six Months Ended June 30,
	2024	2023	2024	2023
Revenue	$49,898	$19,789	$67,482	$28,569
Operating expenses
Research and development	17,225	13,088	30,568	24,136
General and administrative	8,527	9,830	16,955	20,916
Total operating expenses	25,752	22,918	47,523	45,052
Operating income (loss)	24,146	(3,129)	19,959	(16,483)
Other income (expense):
(Loss) gain from equity method investment	(950)	(1,369)	763	(2,710)
Gain (loss) on changes in fair value	694	—	346	(769)
Gain on change in fair value of warrant liability	7,765	—	18,151	—
Interest expense	(560)	(553)	(1,134)	(1,075)
Interest income	1,843	1,946	3,506	3,989
(Loss) gain on disposal of assets	(189)	72	(254)	65
Total other income (expense)	8,603	96	21,378	(500)
Income (loss) from continuing operations	$32,749	$(3,033)	$41,337	$(16,983)
Loss from discontinued operations	—	(8,858)	—	(19,968)
Net income (loss)	$32,749	$(11,891)	$41,337	$(36,951)
Net income (loss) per share
Basic	$4.70	$(3.13)	$6.87	$(9.84)
Diluted	$4.67	$(3.13)	$6.81	$(9.84)
Weighted-average shares of common stock outstanding
Basic	6,966,680	3,803,083	6,013,829	3,756,746
Diluted	7,011,630	3,803,083	6,067,620	3,756,746

Condensed Statements of Changes in

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.